APO Research

APO RESEARCH · REPORT

Sotalol Drug

Selected research

Industry Growth & Trends

Global Sotalol Drug Industry Growth and Trends Forecast to 2032

Market perspective

The global Sotalol Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sotalol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sotalol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sotalol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sotalol Drug include AltaThera Pharmaceuticals, Apotex, Arbor Pharmaceuticals, Epic Pharma, Upsher-Smith Laboratories, Bayer HealthCare, Mylan and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sotalol Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sotalol Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sotalol Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sotalol Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sotalol Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sotalol Drug Market by Company

AltaThera Pharmaceuticals

Apotex

Arbor Pharmaceuticals

Epic Pharma

Upsher-Smith Laboratories

Bayer HealthCare

Mylan

Teva

Sotalol Drug Segment by Type

Injection

Tablet

Oral Solution

Sotalol Drug Segment by Application

Ventricular Arrhythmias

Supraventricular Arrhythmias

Sotalol Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sotalol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sotalol Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sotalol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Tablet Table 3. Major Company of Oral Solution Table 4. Global Sotalol Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Sotalol Drug Sales by Type (2021-2026) & (W Units) Table 6. Global Sotalol Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Sotalol Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Sotalol Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Sotalol Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Sotalol Drug Sales by Type (2027-2032) & (W Units) Table 11. Global Sotalol Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Sotalol Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Sotalol Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Sotalol Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Sotalol Drug Sales by Type (2021-2026) & (W Units) Table 16. North America Sotalol Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Sotalol Drug Sales by Type (2021-2026) & (W Units) Table 18. Europe Sotalol Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Sotalol Drug Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Sotalol Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Sotalol Drug Sales by Type (2021-2026) & (W Units) Table 22. Latin America Sotalol Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Sotalol Drug Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Sotalol Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Sotalol Drug Industry Trends Table 26. Sotalol Drug Industry Drivers Table 27. Sotalol Drug Industry Opportunities and Challenges Table 28. Sotalol Drug Industry Restraints Table 29. Global Sotalol Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Sotalol Drug Revenue Market Share by Company (2021-2026) Table 31. Global Sotalol Drug Sales by Company (2021-2026) & (W Units) Table 32. Global Sotalol Drug Sales Share by Company (2021-2026) Table 33. Global Sotalol Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Sotalol Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Sotalol Drug Major Company Production Sites and Headquarters Table 36. Global Sotalol Drug Company, Product Type & Application Table 37. Global Sotalol Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Sotalol Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Sotalol Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Sotalol Drug Sales by Region (2021-2026) & (W Units) Table 42. Global Sotalol Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Sotalol Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Sotalol Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Sotalol Drug Sales by Region (2027-2032) & (W Units) Table 47. Global Sotalol Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Sotalol Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Sotalol Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Sotalol Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Sotalol Drug Sales by Application (2021-2026) & (W Units) Table 53. Global Sotalol Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Sotalol Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Sotalol Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Sotalol Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Sotalol Drug Sales by Application (2027-2032) & (W Units) Table 58. Global Sotalol Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Sotalol Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Sotalol Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Sotalol Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Sotalol Drug Sales by Application (2021-2026) & (W Units) Table 63. North America Sotalol Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Sotalol Drug Sales by Application (2021-2026) & (W Units) Table 65. Europe Sotalol Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Sotalol Drug Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Sotalol Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Sotalol Drug Sales by Application (2021-2026) & (W Units) Table 69. Latin America Sotalol Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Sotalol Drug Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Sotalol Drug Sales by Application (2021-2026) & (US$ Million) Table 72. AltaThera Pharmaceuticals Company Information Table 73. AltaThera Pharmaceuticals Business Overview Table 74. AltaThera Pharmaceuticals Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AltaThera Pharmaceuticals Sotalol Drug Product Portfolio Table 76. AltaThera Pharmaceuticals Recent Development Table 77. Apotex Company Information Table 78. Apotex Business Overview Table 79. Apotex Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Apotex Sotalol Drug Product Portfolio Table 81. Apotex Recent Development Table 82. Arbor Pharmaceuticals Company Information Table 83. Arbor Pharmaceuticals Business Overview Table 84. Arbor Pharmaceuticals Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Arbor Pharmaceuticals Sotalol Drug Product Portfolio Table 86. Arbor Pharmaceuticals Recent Development Table 87. Epic Pharma Company Information Table 88. Epic Pharma Business Overview Table 89. Epic Pharma Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Epic Pharma Sotalol Drug Product Portfolio Table 91. Epic Pharma Recent Development Table 92. Upsher-Smith Laboratories Company Information Table 93. Upsher-Smith Laboratories Business Overview Table 94. Upsher-Smith Laboratories Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Upsher-Smith Laboratories Sotalol Drug Product Portfolio Table 96. Upsher-Smith Laboratories Recent Development Table 97. Bayer HealthCare Company Information Table 98. Bayer HealthCare Business Overview Table 99. Bayer HealthCare Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bayer HealthCare Sotalol Drug Product Portfolio Table 101. Bayer HealthCare Recent Development Table 102. Mylan Company Information Table 103. Mylan Business Overview Table 104. Mylan Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mylan Sotalol Drug Product Portfolio Table 106. Mylan Recent Development Table 107. Teva Company Information Table 108. Teva Business Overview Table 109. Teva Sotalol Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Teva Sotalol Drug Product Portfolio Table 111. Teva Recent Development Table 112. North America Sotalol Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 113. North America Sotalol Drug Sales by Country (2021-2026) & (W Units) Table 114. North America Sotalol Drug Sales Market Share by Country (2021-2026) Table 115. North America Sotalol Drug Sales Forecast by Country (2027-2032) & (W Units) Table 116. North America Sotalol Drug Sales Market Share Forecast by Country (2027-2032) Table 117. North America Sotalol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Sotalol Drug Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Sotalol Drug Market Share by Country (2021-2026) Table 120. North America Sotalol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Sotalol Drug Market Share Forecast by Country (2027-2032) Table 122. Europe Sotalol Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. Europe Sotalol Drug Sales by Country (2021-2026) & (W Units) Table 124. Europe Sotalol Drug Sales Market Share by Country (2021-2026) Table 125. Europe Sotalol Drug Sales Forecast by Country (2027-2032) & (W Units) Table 126. Europe Sotalol Drug Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Sotalol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Sotalol Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Sotalol Drug Market Share by Country (2021-2026) Table 130. Europe Sotalol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Sotalol Drug Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Sotalol Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Sotalol Drug Sales by Country (2021-2026) & (W Units) Table 134. Asia-Pacific Sotalol Drug Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Sotalol Drug Sales Forecast by Country (2027-2032) & (W Units) Table 136. Asia-Pacific Sotalol Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Sotalol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Sotalol Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Sotalol Drug Market Share by Country (2021-2026) Table 140. Asia-Pacific Sotalol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Sotalol Drug Market Share Forecast by Country (2027-2032) Table 142. Latin America Sotalol Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Latin America Sotalol Drug Sales by Country (2021-2026) & (W Units) Table 144. Latin America Sotalol Drug Sales Market Share by Country (2021-2026) Table 145. Latin America Sotalol Drug Sales Forecast by Country (2027-2032) & (W Units) Table 146. Latin America Sotalol Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Sotalol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Sotalol Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Sotalol Drug Market Share by Country (2021-2026) Table 150. Latin America Sotalol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Sotalol Drug Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Sotalol Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Sotalol Drug Sales by Country (2021-2026) & (W Units) Table 154. Middle East and Africa Sotalol Drug Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Sotalol Drug Sales Forecast by Country (2027-2032) & (W Units) Table 156. Middle East and Africa Sotalol Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Sotalol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Sotalol Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Sotalol Drug Market Share by Country (2021-2026) Table 160. Middle East and Africa Sotalol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Sotalol Drug Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Sotalol Drug Distributors List Table 165. Sotalol Drug Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Sotalol Drug Image Figure 2. Global Sotalol Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sotalol Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Sotalol Drug Sales (2021-2032) & (W Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (W Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 9. Oral Solution Image Figure 10. Global Oral Solution Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Sotalol Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Sotalol Drug Market Share by Type 2025 VS 2032 Figure 13. North America Sotalol Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Sotalol Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Sotalol Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Sotalol Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Sotalol Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Sotalol Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Sotalol Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Sotalol Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Sotalol Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Sotalol Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Sotalol Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Ventricular Arrhythmias Image Figure 26. Global Ventricular Arrhythmias Sales YoY Growth (2021-2032) & (W Units) Figure 27. Supraventricular Arrhythmias Image Figure 28. Global Supraventricular Arrhythmias Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Sotalol Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Sotalol Drug Market Share by Application 2025 VS 2032 Figure 31. North America Sotalol Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Sotalol Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Sotalol Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Sotalol Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Sotalol Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Sotalol Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Sotalol Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Sotalol Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Sotalol Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Sotalol Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Sotalol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Sotalol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Sotalol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Sotalol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sotalol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Sotalol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sotalol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Sotalol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sotalol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Sotalol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sotalol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Sotalol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sotalol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Sotalol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sotalol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Sotalol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sotalol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Sotalol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sotalol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Sotalol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Sotalol Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Sotalol Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Oral Solution
Applications
  • Ventricular Arrhythmias
  • Supraventricular Arrhythmias
Companies covered
  • AltaThera Pharmaceuticals
  • Apotex
  • Arbor Pharmaceuticals
  • Epic Pharma
  • Upsher-Smith Laboratories
  • Bayer HealthCare
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sotalol Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sotalol Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sotalol Drug Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Tablet
  8. 1.3.3 Oral Solution
  9. 1.4 Global Sotalol Drug Market Size by Type
  10. 1.4.1 Global Sotalol Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Sotalol Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Sotalol Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Sotalol Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Sotalol Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Sotalol Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Sotalol Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Sotalol Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sotalol Drug Industry Trends
  2. 2.2 Sotalol Drug Industry Drivers
  3. 2.3 Sotalol Drug Industry Opportunities and Challenges
  4. 2.4 Sotalol Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sotalol Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Sotalol Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Sotalol Drug Price (2021-2026)
  4. 3.4 Global Sotalol Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sotalol Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Sotalol Drug Company, Product Type & Application
  7. 3.7 Global Sotalol Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sotalol Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sotalol Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sotalol Drug Tier 1, Tier 2, and Tier 3
4 Sotalol Drug Regional Status and Outlook
  1. 4.1 Global Sotalol Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sotalol Drug Historic Market Size by Region
  3. 4.2.1 Global Sotalol Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sotalol Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sotalol Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sotalol Drug Forecasted Market Size by Region
  7. 4.3.1 Global Sotalol Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sotalol Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sotalol Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sotalol Drug by Application
  1. 5.1 Sotalol Drug Market by Application
  2. 5.1.1 Ventricular Arrhythmias
  3. 5.1.2 Supraventricular Arrhythmias
  4. 5.2 Global Sotalol Drug Market Size by Application
  5. 5.2.1 Global Sotalol Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Sotalol Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Sotalol Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Sotalol Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Sotalol Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Sotalol Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Sotalol Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Sotalol Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AltaThera Pharmaceuticals
  2. 6.1.1 AltaThera Pharmaceuticals Company Information
  3. 6.1.2 AltaThera Pharmaceuticals Business Overview
  4. 6.1.3 AltaThera Pharmaceuticals Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AltaThera Pharmaceuticals Sotalol Drug Product Portfolio
  6. 6.1.5 AltaThera Pharmaceuticals Recent Developments
  7. 6.2 Apotex
  8. 6.2.1 Apotex Company Information
  9. 6.2.2 Apotex Business Overview
  10. 6.2.3 Apotex Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apotex Sotalol Drug Product Portfolio
  12. 6.2.5 Apotex Recent Developments
  13. 6.3 Arbor Pharmaceuticals
  14. 6.3.1 Arbor Pharmaceuticals Company Information
  15. 6.3.2 Arbor Pharmaceuticals Business Overview
  16. 6.3.3 Arbor Pharmaceuticals Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Arbor Pharmaceuticals Sotalol Drug Product Portfolio
  18. 6.3.5 Arbor Pharmaceuticals Recent Developments
  19. 6.4 Epic Pharma
  20. 6.4.1 Epic Pharma Company Information
  21. 6.4.2 Epic Pharma Business Overview
  22. 6.4.3 Epic Pharma Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Epic Pharma Sotalol Drug Product Portfolio
  24. 6.4.5 Epic Pharma Recent Developments
  25. 6.5 Upsher-Smith Laboratories
  26. 6.5.1 Upsher-Smith Laboratories Company Information
  27. 6.5.2 Upsher-Smith Laboratories Business Overview
  28. 6.5.3 Upsher-Smith Laboratories Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Upsher-Smith Laboratories Sotalol Drug Product Portfolio
  30. 6.5.5 Upsher-Smith Laboratories Recent Developments
  31. 6.6 Bayer HealthCare
  32. 6.6.1 Bayer HealthCare Company Information
  33. 6.6.2 Bayer HealthCare Business Overview
  34. 6.6.3 Bayer HealthCare Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer HealthCare Sotalol Drug Product Portfolio
  36. 6.6.5 Bayer HealthCare Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Sotalol Drug Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Teva
  44. 6.8.1 Teva Company Information
  45. 6.8.2 Teva Business Overview
  46. 6.8.3 Teva Sotalol Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Sotalol Drug Product Portfolio
  48. 6.8.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Sotalol Drug Sales by Country
  2. 7.1.1 North America Sotalol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sotalol Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Sotalol Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sotalol Drug Market Size by Country
  6. 7.2.1 North America Sotalol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sotalol Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Sotalol Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sotalol Drug Sales by Country
  2. 8.1.1 Europe Sotalol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sotalol Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Sotalol Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sotalol Drug Market Size by Country
  6. 8.2.1 Europe Sotalol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sotalol Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sotalol Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sotalol Drug Sales by Country
  2. 9.1.1 Asia-Pacific Sotalol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sotalol Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sotalol Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sotalol Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Sotalol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sotalol Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sotalol Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sotalol Drug Sales by Country
  2. 10.1.1 South America Sotalol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sotalol Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Sotalol Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sotalol Drug Market Size by Country
  6. 10.2.1 South America Sotalol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sotalol Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Sotalol Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sotalol Drug Sales by Country
  2. 11.1.1 Middle East and Africa Sotalol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sotalol Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sotalol Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sotalol Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Sotalol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sotalol Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sotalol Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sotalol Drug Value Chain Analysis
  2. 12.1.1 Sotalol Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sotalol Drug Production Mode & Process
  7. 12.2 Sotalol Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sotalol Drug Distributors
  10. 12.2.3 Sotalol Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research